Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is directly related to the advancement of age. But smoking also plays a vital role in causing AMD. AMD is characterized by the presence of a blurred area near the center of vision that leads to distorted vision. There are two different types of AMD, including dry (atrophic) AMD (dAMD) and wet (neovascular/exudative) AMD (wAMD). The dAMD is the most common type of AMD and accounts for almost 80%-90% of the overall AMD cases.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Age-related Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Age-related Macular Degeneration. This report contains market size and forecasts of Gene Therapy for Age-related Macular Degeneration in global, including the following market information:
Global Gene Therapy for Age-related Macular Degeneration Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Therapy for Age-related Macular Degeneration market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
It has been observed that age-related macular degeneration (AMD) is one of the major causes for vision loss and is characterized by the formation of a blurred area near the center of vision, a condition that mostly affects the geriatric population. According to the CDC, almost 2 million individuals in the US suffer from AMD and by 2050, this number will reach more than 5 million. This will subsequently demand the need for the development of innovative treatments for AMD, driving the market's growth.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Therapy for Age-related Macular Degeneration companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Therapy for Age-related Macular Degeneration Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy for Age-related Macular Degeneration Market Segment Percentages, by Type, 2022 (%)
- Subretinal
- Intravitreal
Global Gene Therapy for Age-related Macular Degeneration Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Therapy for Age-related Macular Degeneration Market Segment Percentages, by Application, 2022 (%)
- Monotherapy
- Combination Therapy
Global Gene Therapy for Age-related Macular Degeneration Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Therapy for Age-related Macular Degeneration Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy for Age-related Macular Degeneration revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Therapy for Age-related Macular Degeneration revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- RetroSense Therapeutics
- REGENXBIO
- AGTC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Therapy for Age-related Macular Degeneration, market overview.
Chapter 2: Global Gene Therapy for Age-related Macular Degeneration market size in revenue.
Chapter 3: Detailed analysis of Gene Therapy for Age-related Macular Degeneration company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Therapy for Age-related Macular Degeneration in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Gene Therapy for Age-related Macular Degeneration Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy for Age-related Macular Degeneration Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy for Age-related Macular Degeneration Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy for Age-related Macular Degeneration Overall Market Size
2.1 Global Gene Therapy for Age-related Macular Degeneration Market Size: 2022 VS 2029
2.2 Global Gene Therapy for Age-related Macular Degeneration Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy for Age-related Macular Degeneration Players in Global Market
3.2 Top Global Gene Therapy for Age-related Macular Degeneration Companies Ranked by Revenue
3.3 Global Gene Therapy for Age-related Macular Degeneration Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy for Age-related Macular Degeneration Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy for Age-related Macular Degeneration Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy for Age-related Macular Degeneration Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy for Age-related Macular Degeneration Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy for Age-related Macular Degeneration Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy for Age-related Macular Degeneration Market Size Markets, 2022 & 2029
4.1.2 Subretinal
4.1.3 Intravitreal
4.2 By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue, 2024-2029
4.2.3 By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy for Age-related Macular Degeneration Market Size, 2022 & 2029
5.1.2 Monotherapy
5.1.3 Combination Therapy
5.2 By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue, 2024-2029
5.2.3 By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Therapy for Age-related Macular Degeneration Market Size, 2022 & 2029
6.2 By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue, 2024-2029
6.2.3 By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2029
6.3.2 US Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.3.3 Canada Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.3.4 Mexico Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2029
6.4.2 Germany Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4.3 France Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4.4 U.K. Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4.5 Italy Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4.6 Russia Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4.7 Nordic Countries Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.4.8 Benelux Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2029
6.5.2 China Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.5.3 Japan Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.5.4 South Korea Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.5.5 Southeast Asia Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.5.6 India Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2029
6.6.2 Brazil Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.6.3 Argentina Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2029
6.7.2 Turkey Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.7.3 Israel Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
6.7.5 UAE Gene Therapy for Age-related Macular Degeneration Market Size, 2018-2029
7 Gene Therapy for Age-related Macular Degeneration Companies Profiles
7.1 RetroSense Therapeutics
7.1.1 RetroSense Therapeutics Company Summary
7.1.2 RetroSense Therapeutics Business Overview
7.1.3 RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Major Product Offerings
7.1.4 RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Revenue in Global Market (2018-2023)
7.1.5 RetroSense Therapeutics Key News & Latest Developments
7.2 REGENXBIO
7.2.1 REGENXBIO Company Summary
7.2.2 REGENXBIO Business Overview
7.2.3 REGENXBIO Gene Therapy for Age-related Macular Degeneration Major Product Offerings
7.2.4 REGENXBIO Gene Therapy for Age-related Macular Degeneration Revenue in Global Market (2018-2023)
7.2.5 REGENXBIO Key News & Latest Developments
7.3 AGTC
7.3.1 AGTC Company Summary
7.3.2 AGTC Business Overview
7.3.3 AGTC Gene Therapy for Age-related Macular Degeneration Major Product Offerings
7.3.4 AGTC Gene Therapy for Age-related Macular Degeneration Revenue in Global Market (2018-2023)
7.3.5 AGTC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gene Therapy for Age-related Macular Degeneration Market Opportunities & Trends in Global Market
Table 2. Gene Therapy for Age-related Macular Degeneration Market Drivers in Global Market
Table 3. Gene Therapy for Age-related Macular Degeneration Market Restraints in Global Market
Table 4. Key Players of Gene Therapy for Age-related Macular Degeneration in Global Market
Table 5. Top Gene Therapy for Age-related Macular Degeneration Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapy for Age-related Macular Degeneration Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapy for Age-related Macular Degeneration Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapy for Age-related Macular Degeneration Product Type
Table 9. List of Global Tier 1 Gene Therapy for Age-related Macular Degeneration Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy for Age-related Macular Degeneration Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Therapy for Age-related Macular Degeneration Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapy for Age-related Macular Degeneration Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Therapy for Age-related Macular Degeneration Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapy for Age-related Macular Degeneration Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2024-2029
Table 30. RetroSense Therapeutics Company Summary
Table 31. RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Product Offerings
Table 32. RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Revenue (US$, Mn) & (2018-2023)
Table 33. RetroSense Therapeutics Key News & Latest Developments
Table 34. REGENXBIO Company Summary
Table 35. REGENXBIO Gene Therapy for Age-related Macular Degeneration Product Offerings
Table 36. REGENXBIO Gene Therapy for Age-related Macular Degeneration Revenue (US$, Mn) & (2018-2023)
Table 37. REGENXBIO Key News & Latest Developments
Table 38. AGTC Company Summary
Table 39. AGTC Gene Therapy for Age-related Macular Degeneration Product Offerings
Table 40. AGTC Gene Therapy for Age-related Macular Degeneration Revenue (US$, Mn) & (2018-2023)
Table 41. AGTC Key News & Latest Developments
List of Figures
Figure 1. Gene Therapy for Age-related Macular Degeneration Segment by Type in 2022
Figure 2. Gene Therapy for Age-related Macular Degeneration Segment by Application in 2022
Figure 3. Global Gene Therapy for Age-related Macular Degeneration Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy for Age-related Macular Degeneration Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Therapy for Age-related Macular Degeneration Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy for Age-related Macular Degeneration Revenue in 2022
Figure 8. By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 16. US Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 20. Germany Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 28. China Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Therapy for Age-related Macular Degeneration Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Therapy for Age-related Macular Degeneration Revenue, (US$, Mn), 2018-2029
Figure 41. RetroSense Therapeutics Gene Therapy for Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. REGENXBIO Gene Therapy for Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AGTC Gene Therapy for Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
